Neurogene (NGNE) Non-Current Assets (2013 - 2026)

Neurogene (NGNE) has 14 years of Non-Current Assets data on file, last reported at $16.4 million in Q1 2026.

• Quarterly Non-Current Assets fell 13.27% year-over-year to $16.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $68.9 million (down 13.76% YoY) and the FY2025 annual result came in at $16.8 million, down 15.01% from the prior year.
• Non-Current Assets declined to $16.4 million in Q1 2026, from $16.8 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $24.5 million in Q4 2022 to a low of $9.7 million in Q3 2023.
• A 5-year average of $17.9 million and a median of $18.5 million in 2022 frame the typical range for Non-Current Assets.
• Annual changes were most pronounced in 2023 — Non-Current Assets tumbled 45.3% — and 2024, when it jumped 111.21%.
• Tracing NGNE's Non-Current Assets over 5 years: stood at $24.5 million in 2022, then retreated by 9.46% to $22.2 million in 2023, then fell by 10.88% to $19.8 million in 2024, then declined by 15.01% to $16.8 million in 2025, then retreated by 2.61% to $16.4 million in 2026.
• The last three Non-Current Assets figures came in at $16.4 million (Q1 2026), $16.8 million (Q4 2025), and $17.3 million (Q3 2025), per Business Quant data.